Establishment of China R&D Coordination Division
First written in FY2017. 4 of 7 entries say "Restated". Latest entry: FY2024.
3 other companies' latest entry also says "Advanced".
- FY2024AdvancedAnnual report
「The company also has product development organizations at its Chinese subsidiaries in Suzhou and Ningbo and is working to identify local needs and strengthen its ability to serve customers in the Chinese market.」
The disclosed structure places product development functions at the Chinese subsidiary in both Suzhou and Ningbo, expanding the sites supporting responsiveness to local needs. - FY2022AdvancedAnnual report
「The Company has also established a product development site at its Chinese subsidiary in Suzhou to identify local needs and strengthen customer responsiveness in the Chinese market.」
The Company has established a product development site at its Chinese subsidiary in Suzhou, putting in place specific measures to identify local needs and strengthen customer responsiveness in the Chinese market. - FY2021-Q3RestatedAnnual report
「Under these conditions, the Group is thoroughly implementing measures to prevent infection with the novel coronavirus while responding swiftly and flexibly to changes in market and customer needs. To strengthen the earnings base of existing businesses and create new business fields, it is expanding R&D functions and production capacity at its Chinese business bases, promoting cross-organizational strategies focused on synergies among businesses in growth fields such as automotive, energy, and healthcare, and establishing an ongoing new-business development structure that anticipates future changes in the social environment and technological innovation.」
The Company continues to pursue the expansion of R&D functions at its Chinese operating sites, together with increased production capacity and cross-functional strategies in growth fields. - FY2021-Q2RestatedAnnual report
「Expansion of R&D functions and production capacity at Chinese operating sites」
To respond to changing needs in the Chinese market, the Company continues to pursue the expansion of R&D functions and production capacity at its Chinese operating sites. - FY2021-Q1RestatedAnnual report
「Under these conditions, the Group is thoroughly implementing measures to prevent infection with the novel coronavirus while responding swiftly and flexibly to changes in market and customer needs. To strengthen the earnings base of existing businesses and create new business fields, it is expanding R&D functions and production capacity at its Chinese business bases, promoting cross-organizational strategies focused on synergies among businesses in growth fields such as automotive, energy, and healthcare, and establishing an ongoing new-business development structure that anticipates future changes in the social environment and technological innovation.」
The Company continues to pursue a policy of expanding R&D functions at its Chinese operating sites to improve its ability to respond to changing needs in the Chinese market. - FY2018RestatedAnnual report
「To identify needs in the Chinese market and strengthen customer responsiveness, the Company has established an R&D headquarters function at its Chinese subsidiary in Suzhou.」
The Company has established an R&D headquarters function at its Chinese subsidiary in Suzhou and continues to maintain a structure that improves its ability to identify needs in the Chinese market and respond to customers. - FY2017First statedAnnual report
「The Company will establish a China R&D headquarters function to improve its ability to identify and address needs in the Chinese market,」
The establishment of a China R&D headquarters function is presented as a specific measure to identify needs in the Chinese market and improve responsiveness.